The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global DOA (Drug of Abuse) Readers Market Research Report 2024
Synopsis
The DOA reader is designed to qualitatively measure drugs of abuse from urine, saliva, or whole blood samples. The system is intended for use in in vitro diagnostics as an aid in monitoring the effectiveness of drugs of abuse. It must be used by the relevant personnel together with the corresponding drug test strips.
Due to the COVID-19 pandemic, the global DOA (Drug of Abuse) Readers market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe DOA (Drug of Abuse) Readers market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe DOA (Drug of Abuse) Readers landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Handheld DOA Reader accounting for % of the DOA (Drug of Abuse) Readers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of DOA (Drug of Abuse) Readers include Prometheus, T-READER, DIALAB, Princeton BioMeditech, Abbott, Zhejiang Orient Gene Biotech, Assure Tech (Hangzhou), Wuhan NanoDiagnosis For Health Biotechnology and Simple & Smart Instrument (Nanjing), etc. In terms of revenue, the global 3 largest players have a % market share of DOA (Drug of Abuse) Readers in 2021.
This report focuses on DOA (Drug of Abuse) Readers volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall DOA (Drug of Abuse) Readers market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global DOA (Drug of Abuse) Readers Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Handheld DOA Reader
Desktop DOA Reader
Segment by Application
Hospitals
Laboratories
Defense Security
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Prometheus
T-READER
DIALAB
Princeton BioMeditech
Abbott
Zhejiang Orient Gene Biotech
Assure Tech (Hangzhou)
Wuhan NanoDiagnosis For Health Biotechnology
Simple & Smart Instrument (Nanjing)
Xuzhou Anding Biotechnology
Guangdong Jindun Electronic Technology
The DOA reader is designed to qualitatively measure drugs of abuse from urine, saliva, or whole blood samples. The system is intended for use in in vitro diagnostics as an aid in monitoring the effectiveness of drugs of abuse. It must be used by the relevant personnel together with the corresponding drug test strips.
Due to the COVID-19 pandemic, the global DOA (Drug of Abuse) Readers market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe DOA (Drug of Abuse) Readers market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe DOA (Drug of Abuse) Readers landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Handheld DOA Reader accounting for % of the DOA (Drug of Abuse) Readers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of DOA (Drug of Abuse) Readers include Prometheus, T-READER, DIALAB, Princeton BioMeditech, Abbott, Zhejiang Orient Gene Biotech, Assure Tech (Hangzhou), Wuhan NanoDiagnosis For Health Biotechnology and Simple & Smart Instrument (Nanjing), etc. In terms of revenue, the global 3 largest players have a % market share of DOA (Drug of Abuse) Readers in 2021.
This report focuses on DOA (Drug of Abuse) Readers volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall DOA (Drug of Abuse) Readers market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global DOA (Drug of Abuse) Readers Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Handheld DOA Reader
Desktop DOA Reader
Segment by Application
Hospitals
Laboratories
Defense Security
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Prometheus
T-READER
DIALAB
Princeton BioMeditech
Abbott
Zhejiang Orient Gene Biotech
Assure Tech (Hangzhou)
Wuhan NanoDiagnosis For Health Biotechnology
Simple & Smart Instrument (Nanjing)
Xuzhou Anding Biotechnology
Guangdong Jindun Electronic Technology
Index1 DOA (Drug of Abuse) Readers Market Overview
1.1 Product Overview and Scope of DOA (Drug of Abuse) Readers
1.2 DOA (Drug of Abuse) Readers Segment by Type
1.2.1 Global DOA (Drug of Abuse) Readers Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Handheld DOA Reader
1.2.3 Desktop DOA Reader
1.3 DOA (Drug of Abuse) Readers Segment by Application
1.3.1 Global DOA (Drug of Abuse) Readers Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Defense Security
1.3.5 Others
1.4 Global DOA (Drug of Abuse) Readers Market Size Estimates and Forecasts
1.4.1 Global DOA (Drug of Abuse) Readers Revenue 2017-2028
1.4.2 Global DOA (Drug of Abuse) Readers Sales 2017-2028
1.4.3 DOA (Drug of Abuse) Readers Market Size by Region: 2017 Versus 2021 Versus 2028
2 DOA (Drug of Abuse) Readers Market Competition by Manufacturers
2.1 Global DOA (Drug of Abuse) Readers Sales Market Share by Manufacturers (2017-2022)
2.2 Global DOA (Drug of Abuse) Readers Revenue Market Share by Manufacturers (2017-2022)
2.3 Global DOA (Drug of Abuse) Readers Average Price by Manufacturers (2017-2022)
2.4 Manufacturers DOA (Drug of Abuse) Readers Manufacturing Sites, Area Served, Product Type
2.5 DOA (Drug of Abuse) Readers Market Competitive Situation and Trends
2.5.1 DOA (Drug of Abuse) Readers Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest DOA (Drug of Abuse) Readers Players Market Share by Revenue
2.5.3 Global DOA (Drug of Abuse) Readers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DOA (Drug of Abuse) Readers Retrospective Market Scenario by Region
3.1 Global DOA (Drug of Abuse) Readers Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global DOA (Drug of Abuse) Readers Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America DOA (Drug of Abuse) Readers Market Facts & Figures by Country
3.3.1 North America DOA (Drug of Abuse) Readers Sales by Country
3.3.2 North America DOA (Drug of Abuse) Readers Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe DOA (Drug of Abuse) Readers Market Facts & Figures by Country
3.4.1 Europe DOA (Drug of Abuse) Readers Sales by Country
3.4.2 Europe DOA (Drug of Abuse) Readers Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific DOA (Drug of Abuse) Readers Market Facts & Figures by Region
3.5.1 Asia Pacific DOA (Drug of Abuse) Readers Sales by Region
3.5.2 Asia Pacific DOA (Drug of Abuse) Readers Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America DOA (Drug of Abuse) Readers Market Facts & Figures by Country
3.6.1 Latin America DOA (Drug of Abuse) Readers Sales by Country
3.6.2 Latin America DOA (Drug of Abuse) Readers Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa DOA (Drug of Abuse) Readers Market Facts & Figures by Country
3.7.1 Middle East and Africa DOA (Drug of Abuse) Readers Sales by Country
3.7.2 Middle East and Africa DOA (Drug of Abuse) Readers Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global DOA (Drug of Abuse) Readers Historic Market Analysis by Type
4.1 Global DOA (Drug of Abuse) Readers Sales Market Share by Type (2017-2022)
4.2 Global DOA (Drug of Abuse) Readers Revenue Market Share by Type (2017-2022)
4.3 Global DOA (Drug of Abuse) Readers Price by Type (2017-2022)
5 Global DOA (Drug of Abuse) Readers Historic Market Analysis by Application
5.1 Global DOA (Drug of Abuse) Readers Sales Market Share by Application (2017-2022)
5.2 Global DOA (Drug of Abuse) Readers Revenue Market Share by Application (2017-2022)
5.3 Global DOA (Drug of Abuse) Readers Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Prometheus
6.1.1 Prometheus Corporation Information
6.1.2 Prometheus Description and Business Overview
6.1.3 Prometheus DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Prometheus DOA (Drug of Abuse) Readers Product Portfolio
6.1.5 Prometheus Recent Developments/Updates
6.2 T-READER
6.2.1 T-READER Corporation Information
6.2.2 T-READER Description and Business Overview
6.2.3 T-READER DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.2.4 T-READER DOA (Drug of Abuse) Readers Product Portfolio
6.2.5 T-READER Recent Developments/Updates
6.3 DIALAB
6.3.1 DIALAB Corporation Information
6.3.2 DIALAB Description and Business Overview
6.3.3 DIALAB DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.3.4 DIALAB DOA (Drug of Abuse) Readers Product Portfolio
6.3.5 DIALAB Recent Developments/Updates
6.4 Princeton BioMeditech
6.4.1 Princeton BioMeditech Corporation Information
6.4.2 Princeton BioMeditech Description and Business Overview
6.4.3 Princeton BioMeditech DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Princeton BioMeditech DOA (Drug of Abuse) Readers Product Portfolio
6.4.5 Princeton BioMeditech Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Abbott DOA (Drug of Abuse) Readers Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Zhejiang Orient Gene Biotech
6.6.1 Zhejiang Orient Gene Biotech Corporation Information
6.6.2 Zhejiang Orient Gene Biotech Description and Business Overview
6.6.3 Zhejiang Orient Gene Biotech DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Zhejiang Orient Gene Biotech DOA (Drug of Abuse) Readers Product Portfolio
6.6.5 Zhejiang Orient Gene Biotech Recent Developments/Updates
6.7 Assure Tech (Hangzhou)
6.6.1 Assure Tech (Hangzhou) Corporation Information
6.6.2 Assure Tech (Hangzhou) Description and Business Overview
6.6.3 Assure Tech (Hangzhou) DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Assure Tech (Hangzhou) DOA (Drug of Abuse) Readers Product Portfolio
6.7.5 Assure Tech (Hangzhou) Recent Developments/Updates
6.8 Wuhan NanoDiagnosis For Health Biotechnology
6.8.1 Wuhan NanoDiagnosis For Health Biotechnology Corporation Information
6.8.2 Wuhan NanoDiagnosis For Health Biotechnology Description and Business Overview
6.8.3 Wuhan NanoDiagnosis For Health Biotechnology DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Wuhan NanoDiagnosis For Health Biotechnology DOA (Drug of Abuse) Readers Product Portfolio
6.8.5 Wuhan NanoDiagnosis For Health Biotechnology Recent Developments/Updates
6.9 Simple & Smart Instrument (Nanjing)
6.9.1 Simple & Smart Instrument (Nanjing) Corporation Information
6.9.2 Simple & Smart Instrument (Nanjing) Description and Business Overview
6.9.3 Simple & Smart Instrument (Nanjing) DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Simple & Smart Instrument (Nanjing) DOA (Drug of Abuse) Readers Product Portfolio
6.9.5 Simple & Smart Instrument (Nanjing) Recent Developments/Updates
6.10 Xuzhou Anding Biotechnology
6.10.1 Xuzhou Anding Biotechnology Corporation Information
6.10.2 Xuzhou Anding Biotechnology Description and Business Overview
6.10.3 Xuzhou Anding Biotechnology DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Xuzhou Anding Biotechnology DOA (Drug of Abuse) Readers Product Portfolio
6.10.5 Xuzhou Anding Biotechnology Recent Developments/Updates
6.11 Guangdong Jindun Electronic Technology
6.11.1 Guangdong Jindun Electronic Technology Corporation Information
6.11.2 Guangdong Jindun Electronic Technology DOA (Drug of Abuse) Readers Description and Business Overview
6.11.3 Guangdong Jindun Electronic Technology DOA (Drug of Abuse) Readers Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Guangdong Jindun Electronic Technology DOA (Drug of Abuse) Readers Product Portfolio
6.11.5 Guangdong Jindun Electronic Technology Recent Developments/Updates
7 DOA (Drug of Abuse) Readers Manufacturing Cost Analysis
7.1 DOA (Drug of Abuse) Readers Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of DOA (Drug of Abuse) Readers
7.4 DOA (Drug of Abuse) Readers Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 DOA (Drug of Abuse) Readers Distributors List
8.3 DOA (Drug of Abuse) Readers Customers
9 DOA (Drug of Abuse) Readers Market Dynamics
9.1 DOA (Drug of Abuse) Readers Industry Trends
9.2 DOA (Drug of Abuse) Readers Market Drivers
9.3 DOA (Drug of Abuse) Readers Market Challenges
9.4 DOA (Drug of Abuse) Readers Market Restraints
10 Global Market Forecast
10.1 DOA (Drug of Abuse) Readers Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of DOA (Drug of Abuse) Readers by Type (2023-2028)
10.1.2 Global Forecasted Revenue of DOA (Drug of Abuse) Readers by Type (2023-2028)
10.2 DOA (Drug of Abuse) Readers Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of DOA (Drug of Abuse) Readers by Application (2023-2028)
10.2.2 Global Forecasted Revenue of DOA (Drug of Abuse) Readers by Application (2023-2028)
10.3 DOA (Drug of Abuse) Readers Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of DOA (Drug of Abuse) Readers by Region (2023-2028)
10.3.2 Global Forecasted Revenue of DOA (Drug of Abuse) Readers by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global DOA (Drug of Abuse) Readers Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global DOA (Drug of Abuse) Readers Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global DOA (Drug of Abuse) Readers Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global DOA (Drug of Abuse) Readers Market Competitive Situation by Manufacturers in 2021
Table 5. Global DOA (Drug of Abuse) Readers Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global DOA (Drug of Abuse) Readers Sales Market Share by Manufacturers (2017-2022)
Table 7. Global DOA (Drug of Abuse) Readers Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global DOA (Drug of Abuse) Readers Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market DOA (Drug of Abuse) Readers Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers DOA (Drug of Abuse) Readers Manufacturing Sites and Area Served
Table 11. Manufacturers DOA (Drug of Abuse) Readers Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global DOA (Drug of Abuse) Readers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DOA (Drug of Abuse) Readers as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global DOA (Drug of Abuse) Readers Sales by Region (2017-2022) & (K Units)
Table 16. Global DOA (Drug of Abuse) Readers Sales Market Share by Region (2017-2022)
Table 17. Global DOA (Drug of Abuse) Readers Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global DOA (Drug of Abuse) Readers Revenue Market Share by Region (2017-2022)
Table 19. North America DOA (Drug of Abuse) Readers Sales by Country (2017-2022) & (K Units)
Table 20. North America DOA (Drug of Abuse) Readers Sales Market Share by Country (2017-2022)
Table 21. North America DOA (Drug of Abuse) Readers Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America DOA (Drug of Abuse) Readers Revenue Market Share by Country (2017-2022)
Table 23. Europe DOA (Drug of Abuse) Readers Sales by Country (2017-2022) & (K Units)
Table 24. Europe DOA (Drug of Abuse) Readers Sales Market Share by Country (2017-2022)
Table 25. Europe DOA (Drug of Abuse) Readers Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe DOA (Drug of Abuse) Readers Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific DOA (Drug of Abuse) Readers Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific DOA (Drug of Abuse) Readers Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific DOA (Drug of Abuse) Readers Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific DOA (Drug of Abuse) Readers Revenue Market Share by Region (2017-2022)
Table 31. Latin America DOA (Drug of Abuse) Readers Sales by Country (2017-2022) & (K Units)
Table 32. Latin America DOA (Drug of Abuse) Readers Sales Market Share by Country (2017-2022)
Table 33. Latin America DOA (Drug of Abuse) Readers Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America DOA (Drug of Abuse) Readers Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa DOA (Drug of Abuse) Readers Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa DOA (Drug of Abuse) Readers Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa DOA (Drug of Abuse) Readers Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa DOA (Drug of Abuse) Readers Revenue Market Share by Country (2017-2022)
Table 39. Global DOA (Drug of Abuse) Readers Sales by Type (2017-2022) & (K Units)
Table 40. Global DOA (Drug of Abuse) Readers Sales Market Share by Type (2017-2022)
Table 41. Global DOA (Drug of Abuse) Readers Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global DOA (Drug of Abuse) Readers Revenue Share by Type (2017-2022)
Table 43. Global DOA (Drug of Abuse) Readers Price by Type (2017-2022) & (US$/Unit)
Table 44. Global DOA (Drug of Abuse) Readers Sales (K Units) by Application (2017-2022)
Table 45. Global DOA (Drug of Abuse) Readers Sales Market Share by Application (2017-2022)
Table 46. Global DOA (Drug of Abuse) Readers Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global DOA (Drug of Abuse) Readers Revenue Share by Application (2017-2022)
Table 48. Global DOA (Drug of Abuse) Readers Price by Application (2017-2022) & (US$/Unit)
Table 49. Prometheus Corporation Information
Table 50. Prometheus Description and Business Overview
Table 51. Prometheus DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Prometheus DOA (Drug of Abuse) Readers Product
Table 53. Prometheus Recent Developments/Updates
Table 54. T-READER Corporation Information
Table 55. T-READER Description and Business Overview
Table 56. T-READER DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. T-READER DOA (Drug of Abuse) Readers Product
Table 58. T-READER Recent Developments/Updates
Table 59. DIALAB Corporation Information
Table 60. DIALAB Description and Business Overview
Table 61. DIALAB DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. DIALAB DOA (Drug of Abuse) Readers Product
Table 63. DIALAB Recent Developments/Updates
Table 64. Princeton BioMeditech Corporation Information
Table 65. Princeton BioMeditech Description and Business Overview
Table 66. Princeton BioMeditech DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Princeton BioMeditech DOA (Drug of Abuse) Readers Product
Table 68. Princeton BioMeditech Recent Developments/Updates
Table 69. Abbott Corporation Information
Table 70. Abbott Description and Business Overview
Table 71. Abbott DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Abbott DOA (Drug of Abuse) Readers Product
Table 73. Abbott Recent Developments/Updates
Table 74. Zhejiang Orient Gene Biotech Corporation Information
Table 75. Zhejiang Orient Gene Biotech Description and Business Overview
Table 76. Zhejiang Orient Gene Biotech DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Zhejiang Orient Gene Biotech DOA (Drug of Abuse) Readers Product
Table 78. Zhejiang Orient Gene Biotech Recent Developments/Updates
Table 79. Assure Tech (Hangzhou) Corporation Information
Table 80. Assure Tech (Hangzhou) Description and Business Overview
Table 81. Assure Tech (Hangzhou) DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Assure Tech (Hangzhou) DOA (Drug of Abuse) Readers Product
Table 83. Assure Tech (Hangzhou) Recent Developments/Updates
Table 84. Wuhan NanoDiagnosis For Health Biotechnology Corporation Information
Table 85. Wuhan NanoDiagnosis For Health Biotechnology Description and Business Overview
Table 86. Wuhan NanoDiagnosis For Health Biotechnology DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Wuhan NanoDiagnosis For Health Biotechnology DOA (Drug of Abuse) Readers Product
Table 88. Wuhan NanoDiagnosis For Health Biotechnology Recent Developments/Updates
Table 89. Simple & Smart Instrument (Nanjing) Corporation Information
Table 90. Simple & Smart Instrument (Nanjing) Description and Business Overview
Table 91. Simple & Smart Instrument (Nanjing) DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Simple & Smart Instrument (Nanjing) DOA (Drug of Abuse) Readers Product
Table 93. Simple & Smart Instrument (Nanjing) Recent Developments/Updates
Table 94. Xuzhou Anding Biotechnology Corporation Information
Table 95. Xuzhou Anding Biotechnology Description and Business Overview
Table 96. Xuzhou Anding Biotechnology DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Xuzhou Anding Biotechnology DOA (Drug of Abuse) Readers Product
Table 98. Xuzhou Anding Biotechnology Recent Developments/Updates
Table 99. Guangdong Jindun Electronic Technology Corporation Information
Table 100. Guangdong Jindun Electronic Technology Description and Business Overview
Table 101. Guangdong Jindun Electronic Technology DOA (Drug of Abuse) Readers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Guangdong Jindun Electronic Technology DOA (Drug of Abuse) Readers Product
Table 103. Guangdong Jindun Electronic Technology Recent Developments/Updates
Table 104. Production Base and Market Concentration Rate of Raw Material
Table 105. Key Suppliers of Raw Materials
Table 106. DOA (Drug of Abuse) Readers Distributors List
Table 107. DOA (Drug of Abuse) Readers Customers List
Table 108. DOA (Drug of Abuse) Readers Market Trends
Table 109. DOA (Drug of Abuse) Readers Market Drivers
Table 110. DOA (Drug of Abuse) Readers Market Challenges
Table 111. DOA (Drug of Abuse) Readers Market Restraints
Table 112. Global DOA (Drug of Abuse) Readers Sales Forecast by Type (2023-2028) & (K Units)
Table 113. Global DOA (Drug of Abuse) Readers Sales Market Share Forecast by Type (2023-2028)
Table 114. Global DOA (Drug of Abuse) Readers Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 115. Global DOA (Drug of Abuse) Readers Revenue Market Share Forecast by Type (2023-2028)
Table 116. Global DOA (Drug of Abuse) Readers Sales Forecast by Application (2023-2028) & (K Units)
Table 117. Global DOA (Drug of Abuse) Readers Sales Market Share Forecast by Application (2023-2028)
Table 118. Global DOA (Drug of Abuse) Readers Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 119. Global DOA (Drug of Abuse) Readers Revenue Market Share Forecast by Application (2023-2028)
Table 120. Global DOA (Drug of Abuse) Readers Sales Forecast by Region (2023-2028) & (K Units)
Table 121. Global DOA (Drug of Abuse) Readers Sales Market Share Forecast by Region (2023-2028)
Table 122. Global DOA (Drug of Abuse) Readers Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 123. Global DOA (Drug of Abuse) Readers Revenue Market Share Forecast by Region (2023-2028)
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of DOA (Drug of Abuse) Readers
Figure 2. Global DOA (Drug of Abuse) Readers Market Share by Type in 2021 & 2028
Figure 3. Handheld DOA Reader Product Picture
Figure 4. Desktop DOA Reader Product Picture
Figure 5. Global DOA (Drug of Abuse) Readers Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Laboratories
Figure 8. Defense Security
Figure 9. Others
Figure 10. Global DOA (Drug of Abuse) Readers Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global DOA (Drug of Abuse) Readers Market Size (2017-2028) & (US$ Million)
Figure 12. Global DOA (Drug of Abuse) Readers Sales (2017-2028) & (K Units)
Figure 13. DOA (Drug of Abuse) Readers Sales Share by Manufacturers in 2021
Figure 14. Global DOA (Drug of Abuse) Readers Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest DOA (Drug of Abuse) Readers Players: Market Share by Revenue in 2021
Figure 16. DOA (Drug of Abuse) Readers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global DOA (Drug of Abuse) Readers Sales Market Share by Region (2017-2022)
Figure 18. Global DOA (Drug of Abuse) Readers Sales Market Share by Region in 2021
Figure 19. Global DOA (Drug of Abuse) Readers Revenue Market Share by Region (2017-2022)
Figure 20. Global DOA (Drug of Abuse) Readers Revenue Market Share by Region in 2021
Figure 21. United States DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Colombia DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE DOA (Drug of Abuse) Readers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of DOA (Drug of Abuse) Readers by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of DOA (Drug of Abuse) Readers
Figure 46. Manufacturing Process Analysis of DOA (Drug of Abuse) Readers
Figure 47. DOA (Drug of Abuse) Readers Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
